|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||47.20 - 47.20|
|52-week range||46.43 - 83.75|
|Beta (5Y monthly)||0.94|
|PE ratio (TTM)||15.07|
|Forward dividend & yield||1.41 (2.72%)|
|Ex-dividend date||13 May 2022|
|1y target est||N/A|
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
HONG KONG, May 12, 2022--Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, today announced its global ‘United in Care’ campaign that celebrates the diversity, unity and positive impact of its nurses and clinical teams across Asia Pacific, Europe, the Middle East and Africa, North America and Latin America.
Fresenius Medical's (FMS) first-quarter earnings benefit from strong performance across all the geographic regions and segments.